Новости за 04.07.2019

by Marek Jankowski, Bogdan A. Danalache, Eric Plante, Ahmed Menaouar, Maria Florian, Ju Jing Tan, Ryszard Grygorczyk, Tom L. Broderick, Jolanta Gutkowska

by Alicja Rzepecka, Magdalena Żmigrodzka, Olga Witkowska-Piłaszewicz, Anna Cywińska, Anna Winnicka

by Lovro Štefan, Petar Paradžik, Goran Sporiš

by Wei Peng, Jia-Wu Li, Xiao-Yun Zhang, Chuan Li, Tian-Fu Wen, Lv-Nan Yan, Jia-Yin Yang

by Jasper Dezwaef, Emiel Cracco, Jelle Demanet, Timothy Desmet, Marcel Brass

by Shih-Chi Wu, Peiling Hsieh, Yi-Wen Chen, Mei-Due Yang, Yu-Chun Wang, Han-Tsung Cheng, Chia-Wei Tzeng, Chia-Hao Hsu, Chih-Hsin Muo

by Xiaowen Long, Xugan Wu, Shaicheng Zhu, Haihui Ye, Yongxu Cheng, Chaoshu Zeng

by Do Hun Kim, Dong Wook Kim, Jin Young Park, Yoo Jin Lee, Hye Jung Choo, Tae Kwun Ha, Soo Jin Jung, Ji Sun Park, Sung Ho Moon, Ki Jung Ahn, Hye Jin Baek

by Felix Ratjen, Renee Jensen, Michelle Klingel, Reginald McDonald, Courtney Moore, Nick Benseler, David Wilson, Sanja Stanojevic

by Thainá Lessa, Janisson W. dos Santos, Ricardo A. Correia, Richard J. Ladle, Ana C. M. Malhado

by Camila Zancheta Ricardo, Catarina Machado Azeredo, Leandro Fórnias Machado de Rezende, Renata Bertazzi Levy

by Diana Hardie, Stephen Korsman, Sharifa Ameer, Lara Vojnov, Nei-Yuan Hsiao

by Niels R. Ntamati, Meaghan Creed, Ridouane Achargui, Christian Lüscher

by Chris M. Stone, Samantha R. Schwab, Dina M. Fonseca, Nina H. Fefferman

by Philip M. Giffard, Steven Y. C. Tong, Deborah C. Holt, Anna P. Ralph, Bart J. Currie

by Yoon Hong Choi, Nick Andrews, Elizabeth Miller

In October 2017, the United Kingdom Joint Committee on Vaccination and Immunisation (JCVI) recommended removal of one primary dose of the 13-valent pneumococcal conjugate vaccine (PCV13) from the existing 2+1 schedule (2, 4, 12 months). We conducted a mathematical modelling study to investigate the potential impact of a 1+1 (3, 12 month) schedule on invasive pneumococcal disease (IPD) and pneumococcal community-acquired pneumonia (CAP). Читать дальше...

by Carlos Ruiz-Arenas, Alejandro Cáceres, Marcos López-Sánchez, Ignacio Tolosana, Luis Pérez-Jurado, Juan R. González

by Aabida Saferali, Jeong H. Yun, Margaret M. Parker, Phuwanat Sakornsakolpat, Robert P. Chase, Andrew Lamb, Brian D. Hobbs, Marike H. Boezen, Xiangpeng Dai, Kim de Jong, Terri H. Beaty, Wenyi Wei, Xiaobo Zhou, Edwin K. Silverman, Michael H. Cho, Peter J. Castaldi, Craig P. Hersh, COPDGene Investigators , the International COPD Genetics Consortium Investigators

by Andrea Komljenovic, Hao Li, Vincenzo Sorrentino, Zoltán Kutalik, Johan Auwerx, Marc Robinson-Rechavi

by Christian L. Vestergaard, Mathieu Génois

by Jesse Gomez, Zonglei Zhen, Kevin S. Weiner

by Yuqiong Hu, Xiaoye Wang, Boqiang Hu, Yunuo Mao, Yidong Chen, Liying Yan, Jun Yong, Ji Dong, Yuan Wei, Wei Wang, Lu Wen, Jie Qiao, Fuchou Tang

"We always try to anticipate the market", explains Edoardo Fassino, CEO of Cover 50, the parent company of PT Torino. "